Long-Term Cost-Effectiveness of Subcutaneous Once-Weekly Semaglutide Versus Polyethylene Glycol Loxenatide for Treatment of Type 2 Diabetes Mellitus in China

OBJECTIVE: This study aimed to evaluate the long-term cost-effectiveness of once-weekly subcutaneous semaglutide versus polyethylene glycol loxenatide (PEG-loxenatide) in patients with type 2 diabetes uncontrolled on metformin, from a Chinese healthcare systems perspective. METHODS: The study applie...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Lei, Ruan, Zhen, Ung, Carolina Oi Lam, Zhang, Yawen, Shen, Yang, Han, Sheng, Jia, Ruxu, Qiao, Jingtao, Hu, Hao, Guo, Lixin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9880095/
https://www.ncbi.nlm.nih.gov/pubmed/36414806
http://dx.doi.org/10.1007/s13300-022-01336-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9880095/
https://www.ncbi.nlm.nih.gov/pubmed/36414806
http://dx.doi.org/10.1007/s13300-022-01336-7

Ejemplares similares